drugset

drugset / Trial / NCT07320612

Efficacy And Safety Of Azithromycin To Achieve Remissionin In Children With Steroid Sensitive Nephrotic Syndrome

NCT07320612 ↗

Phase 1 Completed 160 enrolled University of Child Health Sciences and Children's Hospital, Lahore

RandomizedParallel-groupOpen-labelOther

Summary

To compare efficacy and safety of Azithromycin versus control in children with steroid sensitive nephrotic syndrome

Timeline

Start: 2025-03-08
Primary completion: 2025-08-08
Completion: 2025-10-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Azithromycin	Small molecule	10 mg/kg	Oral

Indications